CGTX
Price
$0.75
Change
+$0.07 (+10.29%)
Updated
Aug 8 closing price
Capitalization
46.77M
94 days until earnings call
PRME
Price
$3.79
Change
+$0.11 (+2.99%)
Updated
Aug 8 closing price
Capitalization
674.77M
82 days until earnings call
Interact to see
Advertisement

CGTX vs PRME

Header iconCGTX vs PRME Comparison
Open Charts CGTX vs PRMEBanner chart's image
Cognition Therapeutics
Price$0.75
Change+$0.07 (+10.29%)
Volume$3.59M
Capitalization46.77M
Prime Medicine
Price$3.79
Change+$0.11 (+2.99%)
Volume$3.59M
Capitalization674.77M
CGTX vs PRME Comparison Chart in %
Loading...
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGTX vs. PRME commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGTX is a Hold and PRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 10, 2025
Stock price -- (CGTX: $0.75 vs. PRME: $3.79)
Brand notoriety: CGTX and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGTX: 38% vs. PRME: 80%
Market capitalization -- CGTX: $46.77M vs. PRME: $674.77M
CGTX [@Biotechnology] is valued at $46.77M. PRME’s [@Biotechnology] market capitalization is $674.77M. The market cap for tickers in the [@Biotechnology] industry ranges from $93.98B to $0. The average market capitalization across the [@Biotechnology] industry is $1.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGTX’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • CGTX’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, CGTX is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGTX’s TA Score shows that 5 TA indicator(s) are bullish while PRME’s TA Score has 3 bullish TA indicator(s).

  • CGTX’s TA Score: 5 bullish, 5 bearish.
  • PRME’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CGTX is a better buy in the short-term than PRME.

Price Growth

CGTX (@Biotechnology) experienced а +28.80% price change this week, while PRME (@Biotechnology) price change was -6.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.25%. For the same industry, the average monthly price growth was +6.85%, and the average quarterly price growth was +13.24%.

Reported Earning Dates

CGTX is expected to report earnings on Nov 12, 2025.

PRME is expected to report earnings on Oct 31, 2025.

Industries' Descriptions

@Biotechnology (+0.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($675M) has a higher market cap than CGTX($46.8M). PRME YTD gains are higher at: 29.623 vs. CGTX (7.586). CGTX has higher annual earnings (EBITDA): -33.03M vs. PRME (-200M). PRME has more cash in the bank: 144M vs. CGTX (16.4M). CGTX has less debt than PRME: CGTX (635K) vs PRME (121M). PRME has higher revenues than CGTX: PRME (3.85M) vs CGTX (0).
CGTXPRMECGTX / PRME
Capitalization46.8M675M7%
EBITDA-33.03M-200M17%
Gain YTD7.58629.62326%
P/E RatioN/AN/A-
Revenue03.85M-
Total Cash16.4M144M11%
Total Debt635K121M1%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGTXPRME
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 7 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KOPN1.920.03
+1.59%
Kopin Corp
VZ43.150.20
+0.47%
Verizon Communications
EWTX12.68-0.27
-2.08%
Edgewise Therapeutics
MMA0.92-0.04
-4.17%
Mixed Martial Arts Group Limited

CGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGTX has been loosely correlated with VOR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CGTX jumps, then VOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGTX
1D Price
Change %
CGTX100%
+11.45%
VOR - CGTX
35%
Loosely correlated
N/A
PRME - CGTX
33%
Poorly correlated
+2.85%
OVID - CGTX
33%
Poorly correlated
+0.66%
LYRA - CGTX
32%
Poorly correlated
-2.76%
LGVN - CGTX
31%
Poorly correlated
-46.62%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+2.85%
CRSP - PRME
59%
Loosely correlated
-2.38%
BEAM - PRME
55%
Loosely correlated
-1.34%
RXRX - PRME
54%
Loosely correlated
-0.92%
CRBU - PRME
49%
Loosely correlated
-4.42%
CCCC - PRME
48%
Loosely correlated
-3.10%
More